Calypte!!! Was seht ihr als realistisches Kursziel
Seite 90 von 106 Neuester Beitrag: 06.10.03 17:08 | ||||
Eröffnet am: | 03.09.03 07:21 | von: Biomedi | Anzahl Beiträge: | 3.625 |
Neuester Beitrag: | 06.10.03 17:08 | von: standingovat. | Leser gesamt: | 91.426 |
Forum: | Hot-Stocks | Leser heute: | 3 | |
Bewertet mit: | ||||
Seite: < 1 | ... | 87 | 88 | 89 | | 91 | 92 | 93 | ... 106 > |
09:42:09 1.180 5000 OTCBB
09:42:01 1.175 500 OTCBB
09:41:31 1.175 500 OTCBB
09:41:22 1.175 11000 OTCBB
Bid: 1.100
Ask: 1.260
Bid/Ask Size: 500 / 500
52 Wk High: 1.799
52 Wk Low: 0.012
%Change: -3.3%
Market Cap: N/A
Price/Sales: N/A
EPS: $0.00
P/E Ratio: N/A
PR Newswire - October 01, 2003 10:10
ALAMEDA, Calif., Oct. 1 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CYPT.OB) announced their participation in a new initiative with the AIDS Action Council to accelerate the accessibility of rapid HIV testing in Africa. The initiative will begin with a five-country tour of Africa -- Tanzania, Kenya, South Africa, Nigeria and Zimbabwe -- to examine the clinical utility of HIV rapid testing and to obtain data on current epidemiological trends in rural regions. Calypte Biomedical will be accompanied in Africa by senior federal legislators, leading activists, and public health officials.
HIV infection is a worldwide epidemic, creating an urgent need for increased identification and counseling of people infected with HIV. Without a vaccine against HIV and with the high cost of treatment, prevention of HIV transmission through testing and education is currently the most effective way to contain the disease. "We have no time to lose in Africa when it comes to accelerating early diagnosis of HIV infection," said Marsha Martin, Executive Director of the AIDS Action Council. "The fate of entire countries may very well be determined by the rate at which we obtain the support necessary to effectively introduce HIV rapid testing in Africa."
Jeannie Gibbs a board member of the AIDS Action Council states that rapid urine testing "offers the best possible option both clinically and economically as it circumvents an almost universal fear of blood tests given people's beliefs that they will catch HIV from the needles. Urine testing will ensure that precious resources are not expended on prohibitively expensive contaminated blood disposal, but is instead directed at expanding the number of people African health officials will be able to test."
According to Dr. Ron Mink Director of Research and Development for Calypte, "Calypte's urine testing eliminates the need for a blood draw, and the use of urine serves to enable an inexpensive and simple sampling process that provides plenty of specimen for followup testing which gives the urine rapid test some distinct advantages over all other approaches."
AIDS Action, founded in 1984, is the national AIDS organization dedicated to the development, analysis, cultivation, and encouragement of sound policies and programs in response to the HIV epidemic. AIDS Action does this through the dissemination of information and the building and use of advocacy on behalf of all those infected with/affected by HIV/AIDS. AIDS Action collaborates with its member organizations and the greater public health community to enhance HIV/AIDS prevention programs and care and treatment services; and to secure comprehensive resources to address community needs until the epidemic is over.
Calypte Biomedical Corporation is dedicated to creating testing solutions for HIV-1, STDs, and other chronic diseases. Calypte's mission is to develop and market in vitro diagnostic testing solutions that make positive contributions to public health and healthcare worldwide. Calypte's urine-based testing algorithm is designed to be safe, cost-effective, and painless, while Calypte's serum-based tests offer proven solutions in a traditional format. By offering both unique urine-based and traditional serum-based testing solutions for HIV infection and other chronic diseases, Calypte can create more opportunities for better healthcare worldwide.
Statements in this press release that are not historical facts are forward-looking statements, including statements regarding announcements of financial results and presentations by the Company. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our product and testing service in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the U.S. Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K for the year ended December 31, 2002 and its subsequent filings with the SEC.
Investor Relations Contact:
Tim Clemensen
212-843-9337
e-mail: tclemensen@rubensteinir.com
SOURCE Calypte Biomedical Corporation
/CONTACT: Investor Relations, Tim Clemensen, +1-212-843-9337,
tclemensen@rubensteinir.com, for Calypte Biomedical Corporation/
/Web site: http://www.calypte.com /
(CYPT CYPT.OB)
Aufträge gewonnen werden können, aber explodieren wir der
Kurs dadurch nicht.
Wir sollten bedenken, das Calypte nich von heute auf Morgen
Millionen von Teststreifen verkauft, sondern die Länder
und Organisationen müssen erst darauf Aufmerksam werden, das dauert
halt seine Zeit.
Mittel-Langfristig is das aber eindeutig Strong Buy!
bin ich zu blöd - oder läuft realtimekurse bei euch auch nicht ??
mußte System neu konfigurieren und jetzt habe ich dauernd Laufzeitfehler wenn ich Realtimekurse aufrufe !!
Wenn der 1 € nicht hält, dann werden wohl einige Stop-Losse ausgelöst werden. Das kann eine saubere Kettenreaktion werden.
Domino-Day bei Caly heute ?
Sicherlich kann ich jeden verstehen, der erst einmal gewinne mitnehmen will (das habe ich ja auch schon getan, nur sollte er sich nacher nicht ärgern wenn der Kurs irgendwann wieder anzieht und er leider nicht mehr dabei ist.
Gruss sam
gruss sam
0.95 ging nich+ich habs auch noch nich aktuallisiert
ne weitere schwäche wg sl wär möglich,sollte aber spätestens 17.00 stabiler werden:)
mal schauen,wie sich das noch entwickelt
denke das der $ aber halten wird...werd wohl ma n abstauberlimit@0.85€ reingeben;)
mfg kram
Ich gehe aber davon aus, dass der Kurs diese nicht
unterschreitet.
Wenn doch, na dann Prostmahlzeit.
Raus geh ich aber nicht, nich zu diesem Zeitpunkt, wo die nächsten,
vielleicht schon bahnbrechenden News im Anmarsch sind.
Falls deutlich fällt, eher noch nachkaufen.
Gruß